Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.
Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results